Diagnostic Kit SARS-cCo V Antigen Rapid Test
USA Medical
COVID-19/SARS-CoV-2 Antigen Tests did not receive FDA Emergency Use Authorization, nor were the tests cleared or approved to be commercially distributed.
🏥 Medical Devices • 6,627 recalls
USA Medical
COVID-19/SARS-CoV-2 Antigen Tests did not receive FDA Emergency Use Authorization, nor were the tests cleared or approved to be commercially distributed.
Shanghai United Imaging Healthcare Co.
X-ray imaging system positioning image and protocol label is reversed for Flexion and Extension on C-Spine and L-Spine, this will cause the image to be incorrectly labeled and may cause the patient to have a repeat exposure.
MESA BIOTECH
SARS-CoV-2 Test has an increased potential for false positive results, which may lead to a delay in correct diagnosis and treatment.
Siemens Healthcare Diagnostics
Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results
Siemens Healthcare Diagnostics
Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results
Siemens Healthcare Diagnostics
Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results
Olympus Corporation of the Americas
GF-UC140P-AL5 is no longer a compatible endoscope for reprocessing in the OER-Pro and presents an infection control risk to patients
Siemens Healthcare Diagnostics
Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results
SML Distribution
The product was distributed without FDA authorization or clearance for marketing and distribution in the US.
Siemens Healthcare Diagnostics
Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results
Siemens Healthcare Diagnostics
Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results
Point of Care (PoC) rapid test products were distributed to customers who did not have a valid CLIA ID.
Draegar Medical Systems
Software issue resulting in temporary loss of central monitoring functionality.
Siemens Healthcare Diagnostics
Potential for falsely elevated hCG results due to sample carryover in serum and urine patient samples, as well as quality control samples and adjustors.
Siemens Medical Solutions USA
Upgraded software version makes an automatic change in laser configuration settings for "markerless workflow" which may lead to the wrong laser offset coordinates being displayed in the Patient Marking step.
Siemens Medical Solutions USA
Upgraded software version makes an automatic change in laser configuration settings for "markerless workflow" which may lead to the wrong laser offset coordinates being displayed in the Patient Marking step.
Siemens Medical Solutions USA
Upgraded software version makes an automatic change in laser configuration settings for "markerless workflow" which may lead to the wrong laser offset coordinates being displayed in the Patient Marking step.
Potential for false positive results for SARS-CoV-2 in identified lots of cartridges, when used in conjunction with assays containing SARS-CoV-2 targets (NeuMoDx" SARS-CoV-2 Test Strip Cat #300800 and NeuMoDx" Flu A-B/RSV/SARS-CoV-2 Vantage Assay Cat #300900) result incorrect management of patients
Siemens Medical Solutions USA
Upgraded software version makes an automatic change in laser configuration settings for "markerless workflow" which may lead to the wrong laser offset coordinates being displayed in the Patient Marking step.
Matrix Medical Network
Due to COVID-19 Test not being authorized for home sample collection.